Skip to main content

Osteoarthritis And Injury Treatment in India


For an elderly people, who are more prone to injuries due to falls and fractures; the resultant pain and suffering can be far beyond its impact. A simple fall can sometimes obligates the need for extensive surgery; which has to be compromised with the risk associated with it coupled with some other fracture related risks such as immobility, ulcers, clots and muscular atrophy.       

The incidence of these fractures have been most of the times connected with the brittle bone disorders such as osteoporosis; however recently scientists have as well confirmed the role of osteoarthritis in the increased risk of injuries or fractures due to unusual falling. Recently, a global longitudinal study of osteoporosis in women confirmed that, almost 40% of the population; who have had osteoarthritis, experienced 30% more falls and fractures because of it. While the actual cause behind this is not completely understood, scientists have found out some clues; which have been listed as follows:

·         Pain: - There are various studies that have confirmed that musculoskeletal pain at one or many places in our body can severely interfere with our ability to accomplish day to day activities. The study performed by the journal of American Medical Association has confirmed that  the severity of the pain is directly associated with one or the other form of Osteoarthritis.
·         Decreased Function: - People with osteoarthritis have risk factors such as decreased mobility, decreased productivity, muscle weakness and impaired balance that increase their exposure to fall or severe injury.
·         Post Traumatic Injury: - The injuries associated with post traumatic arthritis can be more due to worn out bone or cartilages due to their increased susceptibility to breakage. The injury can be due to anything such as sports injury, military injury, vehicle accidents, fall, etc.

Currently, anti inflammatory drugs can be offered to patients along with some hormonal supplements to manage their osteoarthritis and the pain associated with it. However, applications of these treatments came hand in hand with some other potentially dangerous side effects such as heart trouble, stroke, infections, etc. Fortunately, science and technology have come up till the point, wherein easy and effective alternative options are available in the form of stem cells treatment.

Stem cells are the promising candidates with the inherent possibilities to differentiate into cells of different origin. With the help of advanced medical technology, it is now possible to grow stem cells outside the body in the laboratory under controlled conditions and can be capitalized for treating variety of debilitating disorders such as but not limited to osteoarthritis.

Mesenchymal stem cells isolated from extra embryonic fetal tissues have proven to be the best available source so far with the potency and immunological freedom for allogenic use. It can be a breakthrough if these stem cells get stimulated with patient’s own platelet rich plasma. They can work faster for effective regeneration and reduced inflammation related to the disease.

Thus, preventing osteoarthritis is the only better choice to avoid the risk associated with the disease.


To know more about Osteoarthritis Treatment and Stem Cell therapy visit our website : giostar.com

Comments

Popular posts from this blog

The Dawn Of A New Era Of Regenerative Medicine: Tissue Engineering Comes Of Age

The Dawn Of A New Era Of Regenerative Medicine: Tissue Engineering Comes Of Age   The field of regenerative medicine reached a remarkable milestone recently when four women regained full sexual function after the successful implantation of lab-grown vaginas created from their own cells. The women, aged thirteen to eighteen, were born with a rare medical condition called Mayer-Rokitansky-Küster-Hauser syndrome (MRKHS) which left them with an abnormal or missing vagina. Each woman underwent a newly engineered procedure that involved taking samples of the patient's own cells and growing them into tissue. This tissue was then placed on a scaffold that was hand-sewn with collagen-like fibers and uniquely shaped to fit each woman’s vaginal cavity. Once the organ fully matured, it was implanted into a canal in each woman’s pelvis, along with the hand-sewn scaffolding. Within six months, the biodegradable scaffolding dissolved and, in each of the four women, the lab-grown vaginas began fun...

Black fungus detected in Covid-19 survivors, 8 lose eyesight in Surat | MUCORMYCOSIS

 Black fungus detected in Covid-19 survivors, 8 lose eyesight in Surat | MUCORMYCOSIS At least 40 cases of mucormycosis, also known as black fungus, have been reported from Surat in Gujarat among those who have recovered from Covid-19. Of the 40, eight have lost their eyesight. What is this infection and who is more vulnerable? Cases of mucormycosis, commonly known as black fungus, have been reported from Gujarat among those who have recovered from Covid-19. The number of such cases has increased as Gujarat sees an exponential rise in coronavirus infections. At least eight persons were reported to have lost their eyesight in Surat due to mucormycosis (MM) after recovering from Covid-19. They had to be admitted to hospitals for the sudden loss of vision. In the past 15 days, Surat has reported at least 40 cases of mucormycosis or black fungus including eight who have lost their eyesight. The infection, triggered by Covid-19, is treatable but if left untreated or if the treatment is ...

US Moves to Shut Down 2 Big Stem Cell Therapy Clinics

Federal authorities Wednesday moved to shut down two of the country’s most prominent for-profit providers of stem cell therapy, one of them a network of clinics with more than 100 offices in the United States, including several in the Bay Area. The Food and Drug Administration filed two complaints in federal court requesting permanent injunctions that would stop Florida-based U.S. Stem Cell Clinic and the California Stem Cell Treatment Center from marketing therapies. Both companies have previously been called out by the FDA for providing unproven, unapproved therapies that could put patients at risk. The injunction requests are an aggressive move by the FDA to patrol the consumer stem cell market. The agency has come under mounting pressure by scientists and patient advocates to increase oversight of the growing consumer market, which has been allowed to flourish for years. “In the two cases filed today, the clinics and their leadership have continued to disregard th...